You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 2020134015
Dec 20202706
Jan 20213303
Feb 20211602
Mar 20213204
Apr 20211405
May 2021208
Jun 2021005
Jul 2021006
Aug 2021002
Sep 2021009
Oct 202116020
Nov 202110015
Dec 20211406
Jan 20222202
Feb 20221603
Mar 20222603
Apr 20223402
May 20222201
Jun 20224205
Jul 20222000
Aug 20223005
Sep 20222404
Oct 20223402
Nov 20222207
Dec 20223006
Jan 20232601
Feb 20233407
Mar 20231803
Apr 20231603
May 20231605
Jun 20232802
Jul 202324010
Aug 20233204
Sep 20232205
Oct 20232204
Nov 20234404
Dec 20233801
Jan 20244000
Feb 20243406
Mar 20243201
Total10460202